Clinical trials / NCT02355184
NCT02355184Phase 2Terminated

An Extension of Protocol PRO 140_CD01 Study

Study sponsor: CytoDyn, Inc.

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov recordCSV export · Pro
Primary completion2022-06Actual
Enrollment · participants20Actual
Source updated2025-10-07Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 5 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Compare wording
− Before

Measure: Time to virologic failure after initiating PRO 140 monotherapy.

+ After

Measure: Time to Virologic Failure After Initiating PRO 140 Monotherapy

Participant count type changed

− Before

Estimated

+ After

Actual

Enrollment · participant count changed

− Before

28 participants (planned)

+ After

20 participants (actual)

Completion date type changed

− Before

Estimated

+ After

Actual

Recruitment status changed

− Before

Active not recruiting

+ After

Terminated

Check registry source